CERRITOS, Calif. (June 30, 2017) — Dentistry Today‘s readers have honored the PerioLase® MVP-7™ as one of the top 100 products for 2017. The 31st annual awards are designed to recognize products and technology that is innovative in dentistry.
“This honor from our colleagues and peers follows the one year milestone of FDA clearance for True Regeneration using the PerioLase MVP-7,” comments Robert H. Gregg II, DDS, founder of Millennium Dental Technologies (MDT). “The PerioLase MVP-7 for the LANAP protocol helps clinicians grow their practices while changing the lives of patients who want to save their natural teeth.”
The PerioLase MVP-7 is the only dental laser designed specifically for the LANAP protocol. The laser wavelength targets and destroys the bacteria causing gum disease during a minimally-invasive, highly effective treatment proven to regenerate bone.
“Being honored by readers of Dentistry Today is a point of pride for us, because it reflects the opinions of general dentists and specialists who know the industry,” remarks Dawn M. Gregg, DDS, MDT Vice President and Training Director. “Our customers realize the value in using a treatment method that is more effective and something patients want. As more and more doctors from the dental community invest in our minimally invasive, tissue-sparing, and patented laser protocol, the better chance we have of ending the gum disease epidemic.”
ABOUT MILLENNIUM DENTAL TECHNOLOGIES, INC.: Headquartered in Cerritos, Calif., Millennium Dental Technologies, Inc., is the developer of the LANAP protocol for the treatment of gum disease and the manufacturer of the PerioLase MVP-7 digital dental laser. By providing a simple and comfortable experience with unique bone-building clinical results, MDT’s FDA-cleared LANAP protocol removes the fear from gum disease treatment, offering a less painful and less invasive regenerative treatment alternative to conventional surgery. The Nd:YAG PerioLase MVP-7 has the power and versatility to perform a wide range of laser procedures, including the LAPIP™ protocol for the treatment of ailing dental implants. The company’s founding clinician, Robert H. Gregg, II, continues to operate the company with the vision: To create better clinical outcomes in periodontal disease patients—and to remain true to the guiding principle—”It’s all about the patient.”